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INTRODUCTION:  Alagille  syndrome  is a multisystem  autosomal  disorder.  The  main  clinical  features  are
chronic  cholestasis  due  to  paucity  of  intrahepatic  bile  ducts,  which  can  progress  to cirrhosis  and  liver
failure.
PRESENTATION  OF  CASE:  A  15  year-old  girl  with  Alagille  syndrome  was  referred  for  liver transplantation.
She  developed  severe  cirrhosis  with  refractory  ascites.  In the  pre-transplant  evaluation,  imaging  studies
disclosed  liver  atrophy  with  a high  density  pseudotumor  in  the segment  4,  raising  the  possibility  of  a
hepatocellular  carcinoma.  However,  behavior  of  the lesion  was  highly  suggestive  of  focal  compensatory
hyperplasia  surrounded  by  an  atrophic  liver.  The  patient  was  registered  on  the  waiting  list.
DISCUSSION:  Hepatic  lesions  have  been  described  in Alagille  syndrome  in  isolated  case  reports,  and  most
of these  have  been  reported  to  be  hepatocellular  carcinoma.  However,  they  can  be  related  to an  area  of
focal compensatory  hyperplasia  in  severe  cirrhosis.  These  ﬁndings  may  also  explain  why  progression  of
liver  disease  occurs  only  in 15%  of patients.
CONCLUSION:  The  presence  of a large  hepatic  nodule  Alagille  syndrome  can  be  benign  in these  patients
also  predisposed  to hepatocellular  carcinoma.  Therefore,  cautious  evaluation  with  magnetic  resonance
imaging  study before  liver  transplantation  is  mandatory.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Alagille syndrome, also known as arteriohepatic dysplasia, is a
ultisystem autosomal disorder due to defects in the Notch signal-
ng pathway [1]. This syndrome can affect the liver, heart, skeleton,
yes, kidneys, and central nervous system. Liver involvement is one
f the main clinical features, consisting of chronic cholestasis due
o paucity of interlobular bile ducts [1]. Progressive liver disease,
eading to cirrhosis occurs in approximately 15% of cases and may
equire liver transplantation (LT) [2]. These patients are at risk for
epatocellular carcinoma, therefore early detection of liver tumors
re critical in the management of this disease.
We  describe the case of a patient with known Alagille syndrome
ho developed severe liver cirrhosis. Pre-transplant evaluation dis-
losed a nodular lesion in the segment 4 which corresponded to a
ocal hyperplasia in advanced cirrhosis.
∗ Corresponding author at: Department of Hepato-Gastro-Enterology, Mongi Slim
ospital, Tunis, Tunisia.
E-mail address: rym.ennaifer@yahoo.fr (R. Ennaifer).
ttp://dx.doi.org/10.1016/j.ijscr.2016.03.032
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/).2. Presentation of case
A 15 year-old girl was  referred to our department for evalua-
tion for LT. The diagnosis was  suspected at the age of 2 months
in the presence of jaundice due to cholestasis. Liver biopsy dis-
closed paucity of the intrahepatic bile ducts. A pulmonary stenosis
was further highlighted and treated percutaneously. Moreover,
the patient exhibited the typical dysmorphic facies with a promi-
nent forehead, deep set eyes and pointed chin giving the face
a triangular appearance associated with thoracic vertebral seg-
mentation anomalies called “butterﬂy” vertebrae. In presence of
these clinical features, the diagnosis of Alagille syndrome was
ascertained. The patient’s mother did not have the same physi-
cal features. We  did not disclose ophthalmic and renal anomalies.
Pruritus was successfully treated with ursodeoxycolic acid and
rifampicin, however, liver disease worsened gradually until decom-
pensated cirrhosis at the age of 14 year-old and then refractory
ascites.
At the time of evaluation, laboratory tests were as follow: ele-
vated conjugated bilirubin = 290 mol/l (normal value <5 mol/l)
and gammaglutamyl transpeptidase = 100 IU/l (normal: 30 IU/l),
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Liver ultrasonogram; large mass of the segment 4 isoechoic to the parenchyma.
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secreased prothrombin time = 48%, albumin = 30 g/l and platelets
ount = 67,000/mm3. Her Child-Pugh score was C 11 and Meld score
5.
Liver ultra sound disclosed a large mass of the segment 4
f the liver, nodular in shape, isoechoic to the parenchymal
iver (Fig. 1). The patient underwent a CT scan that revealed an
mportant hypertrophy of the segment 4 of the liver having a
umoral appearance isodense to the liver on unenhanced and
nhanced CT (Fig. 2a and b). The contrast enhancing CT imaging
howed normal hepatic vasculature coursing through the lesion.
he remaining liver segments were atrophic. CT scan showed also
ortal hypertension changes such as splenomegaly and venous
ollateral vessels. MRI, performed several months later, demon-
trated that the mass-like segment 4 was increased in size and
ppeared isointense on T2 weighted images (Fig. 3a). The left
iver lobe was deeply hypotrophic (Fig. 3b). On enhanced MRI
ith gadolinium agents, the pseudotumorous lesion was slightly
yperintense on arterial phase (Fig. 4) and iso-intense on por-
al one (Fig. 5). MRI  showed also splenic necrotic foci areas and
scitis.
Alpha foeto protein level was 1.5 ng/ml (normal range) and
he diagnosis of hepatocellular carcinoma was ruled out. Liver
iopsy was avoided because of haemostasis disorders and ascites,
specially as transjugular route was not available. In view of
hese ﬁndings, a focal compensatory hyperplasia surrounded by
n atrophic liver was the most likely. Therefore, she was listed
or LT. Liver ultrasound performed 1 year later demonstrated the
ame ﬁndings, without any change in the characteristic of the lesion
Fig. 6).
. DiscussionThis is a case of Alagille syndrome who developed severe cirrho-
is with a pseudotumorous focal liver hyperplasia. Cross sectional
tudy were helpful in characterizing this unusual lesion.Alagille syndrome is a complex and rare autosomal domi-
nant disorder [1]. Early cases were essentially ascertained through
neonatal liver disease, as in our case.
The diagnosis is essentially clinical, dominated by chronic
cholestasis and congenital heart disease. Classic criteria, based on
the 5 main systems involved were established: cholestasis due
to bile paucity, congenital heart disease (most commonly periph-
eral pulmonary artery stenosis), the face (mild but recognizable
dysmorphic features), the skeleton (most commonly butterﬂy ver-
tebrae), and the eye (most commonly posterior embryotoxon) [3].
It was  held that the diagnosis is sustainable if bile duct paucity was
accompanied by 3 of the 5 main criteria. Nervertheless, since the
introduction of genetic testing, a wide variety of clinical features are
now recognized [1]. In our case, genetic investigation was  not avail-
able in our country, and the clinical features made the diagnosis of
Alagille syndrome conﬁdent.
The prognosis of the syndrome is related to liver disease and
congenital heart defects. Therapy is generally focused on these 2
organs.
Concerning the liver, paucity of interlobular bile ducts appears
to develop through infancy and is considered as a key feature,
reported in 80–90% in large series [1]. Though, progression does
not always occur and deterioration of liver function and develop-
ment of cirrhosis is reported in only 12% of patients [4]. Among
them, approximately 20% will require LT either for hepatic failure or
refractory pruritus [4]. Moreover, hepatocellular carcinoma (HCC)
has already been described during Alagille syndrome, therefore, a
cautious evaluation before LT is mandatory [5–8].
In this report, the patient was referred for LT because of refrac-
tory ascites while pruritus was  moderate. The nodular lesion seen
on imaging raised the possibility of a HCC, contraindicating LT. Pre-
vious reports have described nodular lesions in the liver associated
with Alagille syndrome; they include hepatocellular carcinoma,
hamartous nodule and regenerating nodules [5–10]. In 3 cases, focal
hyperplasia in advanced cirrhosis has been described [4,11,12]. In
the ﬁrst case, the lesion was  in the caudate lobe, mimicking a tumor
at ultrasonography [11]. At laparotomy, the caudate lobe had a
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Fig. 2. Enhanced CT scan axial images (2a: arterial phase 2b: portal phase).
Pseudonodular hypertrophy of the segment 4 of the liver isointense. Normal vasculature of the liver is showed through the mass.
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dseudotumoral appearance, but at biopsy the liver parenchyma
as preserved, while samples from the right and left lobes showed
n absence of intrahepatic biliay ducts. The diagnosis of Alagille
yndrome with areas free of hypoplasia of the intrahepatic bil-
ary duct was the more likely. In the second case, the patient was
eferred for LT because of severe cirrhosis associated with Alagille
yndrome [4]. He had a high density nodular lesion in the medial
ight lobe of the liver at CT scan. Radionuclides imaging studies
howed severe hepatobiliary dysfunction with an area of increased
ocal uptake in the liver. Pathological evaluation at transplantation
evealed that the focal uptake was an area of focal compensatory
yperplasia in a background of severe biliary cirrhosis [4]. In the
ast and more recent case, during pre-transplantation evaluation,
T and MRI  revealed a large hepatic lesion with multiple small
odular lesions [12]. These latter were considered as hepatic nodu-
ar hyperplasia as large vessels running through the lesion were
emonstrated [12].Our case is similar to these previous reports; despite the
lack of a pathologic study, HCC was ruled out, consequently, LT
was not contra-indicated. Actually, liver biopsy was not prac-
ticed because the patient had ascites and coagulation disorders
and the transjugular route was not available. These 3 previous
reported cases allowed us to exclude a lesion contraindicating LT
using only cross sectional imaging. Moreover, stability of the lesion
during the follow-up ultrasound was  an argument in favour of
benignity.
The possibility of area free of hypoplasia of the intrahepatic bil-
iary ducts may  explain why progression of liver disease in Alagille
syndrome does not always occur, moreover, a small proportion of
patients have no manifestation of liver disease.On the other hand, etiology of liver nodules in Alagille syndrome
may  encounter difﬁculties, and knowledge of this entity is impor-
tant as these patients are also predisposed to HCC. The ﬁrst reports
used pathology and radionuclides imaging to conﬁrm the diagno-
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Fig. 3. (a) T2 weigthed MRI  axial image; a mass-like segment 4 of the liver isointense to the parenchyma. (b) T2 weighted MRI  coronal image; important hypotrophic left
liver  lobe.
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Fig. 4. Arterial phase enhanced MRI; the pseudomass is slightly enhanced.
Fig. 5. Portal phase enhanced MRI; the pseudomass is isointense. Ascitis and necrotic foci of spleen are present.
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is. We  believe that after this case, MRI  and CT scan may  be enough
o conﬁrm the diagnosis.
. Conclusion
Liver nodule in Alagille syndrome may  be related to an area
f focal compensatory hyperplasia in severe cirrhosis, therefore,
autious evaluation before liver transplantation is mandatory in
hese patients also predisposed to HCC. These ﬁndings may  also
xplain why progression of liver disease occurs does not occur in
ll patients.
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